Keir, Christopher H. External Entity

Publications

Sort by

Selected publications

  • Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study.  Clinical lymphoma, myeloma & leukemia2016 Academic Article GET IT

Other